Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors.

In this model, steroid therapy remained the sole independent predictor of VF progression, although it was marginally statistically significant (OR: 8.260 (95 % CI: 0.909–75.095), p = 0.061). 4 Discussion In this study, which enrolled metastatic patients with lung cancer and melanoma, it was found that 7.4 % (10/135) experienced VFs that are notoriously expression of skeletal fragility [9] .

also in 270 other papers